Yann Fichou Receives Harvey Karp Fellowship

“This will inspire new concepts and strategies for ultimately identifying drugs that could prevent or delay pathological changes in alpha-synuclein.This method is expected to be applicable to other systems, such as the tau and amyloid beta proteins associated with Alzheimer’s disease.” - Yann Fichou

http://www.news.ucsb.edu/2016/017126/and-winner